Potential drug targets for ALS and FTD identified in two studies

Potential drug targets for ALS and FTD identified in two studies

A pair of collaborative studies led by Fen-Biao Gao, Ph.D., have identified two potential drug targe...
read more
Historically ‘safer’ tramadol more likely than other opioids to result in prolonged use

Historically ‘safer’ tramadol more likely than other opioids to result in prolonged use

Surgical patients receiving the opioid tramadol ha...
read more
Research into opioid painkillers could provide clues for safer drug development

Research into opioid painkillers could provide clues for safer drug development

Researchers have taken a step closer to understand...
read more
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

IRVINE, Calif. & BASEL, Switzerland–(BUS...
read more
FDA warns Americans not to buy drugs from Canadian company

FDA warns Americans not to buy drugs from Canadian company

(HealthDay)—A large Canadian drug distributor se...
read more
FDA Approves Esperoct

FDA Approves Esperoct

Bagsværd, Denmark, 19 February 2019 – ...
read more
FDA warns 17 companies about illegal Alzheimer disease products

FDA warns 17 companies about illegal Alzheimer disease products

(HealthDay)—A number of warning/advisory letters...
read more
FDA approves cablivi for rare blood-clotting disorder

FDA approves cablivi for rare blood-clotting disorder

(HealthDay)—Cablivi (caplacizumab-yhdp) injectio...
read more
How gut bacteria affect the treatment of Parkinson’s disease

How gut bacteria affect the treatment of Parkinson’s disease

Patients with Parkinson’s disease are treate...
read more
Opioid prescriptions almost twice as likely for rural vs. urban Americans

Opioid prescriptions almost twice as likely for rural vs. urban Americans

(HealthDay)—As the United States battles an epid...
read more